LINDEN ADVISORS LP - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 31 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
LINDEN ADVISORS LP ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,242,669
-61.9%
9,000,000
-50.0%
0.07%
-63.0%
Q2 2023$19,015,740
-22.8%
18,000,000
-10.0%
0.20%
-22.8%
Q1 2023$24,645,58620,000,0000.26%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Antara Capital LP 49,500,000$47,535,0001.45%
ZAZOVE ASSOCIATES LLC 16,238,000$15,254,0001.34%
Kohlberg Kravis Roberts & Co. L.P. 26,000,000$24,456,0000.22%
WEDBUSH SECURITIES INC 30,000$2,807,0000.13%
AVIVA PLC 15,000,000$14,034,0000.07%
Context Capital Management, LLC 1,000$951,0000.06%
LMR Partners LLP 4,500,000$4,242,0000.05%
CAPSTONE INVESTMENT ADVISORS, LLC 15,500,000$14,580,0000.04%
LAZARD ASSET MANAGEMENT LLC 27,770,000$26,121,0000.03%
FRANKLIN RESOURCES INC 48,000,000$45,150,0000.02%
View complete list of REVANCE THERAPEUTICS INC shareholders